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Boronic acid compounds with different substituted groups were handled to synthesize various ligands
encoded as B1, B2, B3, B4, B5, B6, B7 and B8. B5 and B7 were tested for the cytotoxic activity against the
prostate cancer cells and it was found that the cell viability of cancer cells was decreased while most of
the healthy cells could still be viable. 5 mM solutions of B5 and B7 decreased the cell viability to 33% and
44% whereas healthy cells were 71% and 95%, respectively, after treatment. Antimicrobial properties were
explored against the bacterial and fungal microorganisms with B1, B5 and B7. The inhibition zones were
evaluated for all boronic structures, and the growth inhibition zones were determined in a range of
7–13 mm diameter for different microorganism species. Staphylococcus aureus was the common micro-
organism that three boronic compounds with imine ligands showed the activity. Antioxidant features of
B2, B3, B4, B5, B6, B7 and B8 were investigated by different processes such as Beta-carotene bleaching
(BCB), 2,2-diphenyl picryl hydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS)
and CUPric reducing antioxidant capacity (CUPRAC) methods. Signiﬁcant antioxidant activity was
achieved by the phenyl boronic based ligands and these compounds demonstrated as much activity as
standards (α-Toc and BHT). In addition, all structures were applied properly without any decomposition
during the experiments. They were rather stable both in aqueous media and solid state.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Boron exists as a trace element in many kinds of vegetables,
fruits, especially in nuts. Evidences show that the deﬁciency or
excess of boron causes biological inﬂuences [1,2]. It has a sig-
niﬁcant role in hormone and enzyme reactions as well as in the
mineral metabolism system for the cell membrane functions and
boron is a fundamental component for the growth process of
many plants. In addition to this, it has been determined as an
essential necessity for human life so that it is found in human and
animal tissues at mild concentrations [2]. Previous studies have
shown that the deﬁciency of boron is responsible for the decline ofon and hosting by Elsevier B.V. All
University.
eutical Chemistry, Faculty of
key.plant photosynthetic capacity [3–5]. In particular, the lack of boron
minerals negatively affects agricultural crops. These kinds of pro-
blems have urged researchers to focus on boron activities in living
systems [6].
The inadequacy of nutritional boron has an impact on brain
electrophysiology and brain behaviors. Apart from the psycholo-
gical events, boronic compounds have been commonly used in
cancer treatment, which is called as Boron Neutron Capture
Therapy (BNCT) [7]. The treatment is brieﬂy based on capture re-
action between a neutron and 10B isotope. The neutron absorption
by a boronic compound supplies more energy to be efﬁcient in the
biological fraction. Boron and the neutrons cannot cause any tissue
damages by themselves. Various boronic structures have been
exerted in tumor and cancer therapy with limited thriving outputs.
Since BNCT requires a high cost nuclear reactor, it has a restricted
usage worldwide in clinical treatments [8–11].
Literature research also represents that the exchange of boronrights reserved. This is an open access article under the CC BY-NC-ND license
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plant studies have shown that excess of boron stimulates the an-
tioxidant enzymes and particularly activates the enzymes related
to ascorbate cycle [12–15].Scheme 1. Synthesis of B1.
Scheme 2. Synthesis of B2.2. Materials and methods
2.1. Materials and instrumentation
In the present research, eight new boronic compounds con-
taining imine (C¼N) ligands (B1–B8) were synthesized by the
reaction of aromatic amines with phenyl boronic acids bearing
aldehyde group [16,17]. The structural identiﬁcation of synthe-
sized compounds was done by various spectroscopic methods
such as nuclear magnetic resonance (1H and 13C NMR), liquid
chromatography–mass spectroscopy (LC–MS), Fourier transform
infrared (FTIR) spectroscopy, ultraviolet visible (UV–vis) spectro-
scopy, elemental analysis and scanning electron microscope (SEM).
Then, these boronic compounds were explored for the anticancer,
antimicrobial and antioxidant purposes. Prostate cancer cells were
treated with boronic compounds and the cytotoxic behaviors were
identiﬁed. The toxicity levels of these compounds against the
healthy cells were also explored in the present work. Antimicrobial
studies were carried out on different kinds of microorganisms
such as Staphylococcus aureus, Escherichia coli,Methicillin-resistant
Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Candida
albicans, and Aspergillus niger. The boronic-imine structured
compounds have shown considerable efﬁciencies on microorgan-
isms in the previous researches in last decade [16–20]. The anti-
oxidant behavior was investigated by using a variety of methods
such as β-carotene bleaching (BCB), 2,2-diphenyl-1-picrylhydrazyl
(DPPH), CUPric reducing antioxidant capacity (CUPRAC) and 2,2′-
azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS).
All the reagents and chemicals were supplied by Sigma-Aldrich
(Steinheim, Germany) and Fluka (St. Gallen, Switzerland). All the
synthetic pathways were conducted under Ar atmosphere in ap-
propriate glasswares unless otherwise stated. 1H and 13C NMR
spectra were recorded on a Bruker AV400 spectrometer (Karls-
ruhe, Germany) with δ referenced to external tetramethylsilane
(TMS). FTIR spectra were recorded on an attenuated total re-
ﬂectance (ATR) apparatus on a Perkin Elmer Spectrum 100 Fourier
transform spectrophotometer. LC–MS analyses were performed by
a Shimadzu LC/MS 8040 instrument (Kyoto, Japan). Elemental
analysis of carbon, hydrogen and nitrogen was carried out on a
Costech Combustion System CHNS-O instrument (Cernusco S/
Nav.-MI-Italy). Melting points were measured by a Barnstead
Electrothermal 9100 (San Francisco, USA). SEM images were taken
by a FEI Quanta 250 FEG instrument (Eindhoven, Netherlands).
2.2. Methods
2.2.1. Synthesis of boronic derivative compounds
2.2.1.1. Synthesis of B1 (2-(6-methoxynaphthalen-2yl)benzo[d][1,3,2]
dioxaborol4-ol). Pyrogallol (0.126 g, 1 mmol) dissolved in 20 mL of
tetrahydrofurane (THF) was added into the solution of 6-meth-
oxynaphthalene (0.202 g, 1 mmol) prepared in ethanol (20 mL)
and heated under reﬂux for 48 h. The brownish precipitate was
obtained after removal of the solvent, which was washed with
ethanol and dried in an oven. The product is soluble in acetone:
dimethyl sulfoxide (DMSO) (1:1, v/v). Mp (Melting point): 198–
202 °C. 1H NMR (ppm, DMSO-d6): δ 5.44 (Ph–OH), 3.95
(Naph–OCH3). FTIR-ATR (cm1): 1383–1324 ν(B–O), 723 ν(B–Ph).
m/z: 291.08 [MHþ] C17H13BO4 (MW:292.0922 g/mol). UV–vis
(nm): λ1¼296 (Ɛ¼2.96103), λ2¼311 (Ɛ¼3.11103), in acetone:
DMSO (1:1). Elemental analysis (%): Found (Calc.) C 70.86 (69.90),H 4.29 (4.49) (Scheme 1).
2.2.1.2. Synthesis of B2 (Naringenin based boronic acid). Naringenin
(0.275 g, 1 mmol) in 30 mL of absolute ethanol and phenyl boronic
acid (0.121 g, 1 mmol) in 20 mL of ethanol were mixed in a one-
necked ﬂask and heated under reﬂux at 100 °C for 24 h. The yellow
solid product was obtained after removal of the solvent and water,
which was washed with ethanol and water, and then dried in an
oven. The product is soluble in ethanol and DMSO. Mp: 210 °C. 1H
NMR (ppm, DMSO-d6): δ 5.44 (Ph–OH), 6.52–8.01 (Ph–H). FTIR-
ATR (cm1):1364–1334 ν(B–O), 759 ν(B–Ph). m/z: 359 [MþHþ]
C21H15BO5 (MW: 358.15 g/mol). UV–vis (nm): λ1¼216 (Ɛ
¼2.16103), λ2¼334 (Ɛ¼3.34103), in ethanol. Elemental ana-
lysis (%): Found (Calc.) C 67.13 (67.42), H 4.08 (4.02) (Scheme 2).
2.2.1.3. Synthesis of B3 (3-((4-(hydrazine carbonyl) phenyl imino)
methyl) phenyl boronic acid). 4-amino benzoic hydrazide (0.151 g,
1 mmol) in 20 mL of absolute ethanol and 3-formyl phenyl boronic
acid (0.149 g, 1 mmol) in 15 mL of ethanol were mixed in a one-
necked ﬂask and heated under reﬂux at 100 °C for 24 h. The yellow
solid product was precipitated after removal of the solvent
and water, which was washed with ethanol and water, and then
dried in an oven. The product is soluble in ethanol and DMSO.
Mp:350–355 °C. 1H NMR (ppm, DMSO-d6): δ 8.39 (CH¼N),
5.77 (Ph–B(OH)2). FTIR-ATR (cm1): 3300–3200 (BO–H),
759 ν(B–Ph), 1601 ν(CH¼N). m/z: 284 [MþHþ] C14H14N3O3B
(MW: 283.09 g/mol). UV–vis(nm): λ1¼202 (Ɛ¼2.02103),
λ2¼321 (Ɛ¼3.21103), in ethanol. Elemental analysis (%): Found
(Calc.) C 60.16 (59.40), H 3.17 (3.68), N 14.0 (14.34) (Scheme 3).
2.2.1.4. Synthesis of B4 (3-((2,6-dimethoxy phenyl imino) methyl)
phenyl boronic acid). 2,6-dimethoxy aniline (0.153 g, 1 mmol) in
20 mL of absolute ethanol and 3-formyl phenyl boronic acid
(0.149 g, 1 mmol) in 15 mL of ethanol were mixed in a one-necked
ﬂask and heated under reﬂux at 100 °C for 24 h. The yellow solid
product was isolated after removal of the solvent and water, which
was washed with ethanol and water, and then dried in an oven.
The product is soluble in ethanol and DMSO. Mp: 230–240 °C. 1H
NMR (ppm, DMSO-d6): δ 8.61 (CH¼N), 5.05 (Ph–B(OH)2).
FTIR-ATR(cm1): 3371 (BO–H), 1585 ν(CH¼N). m/z: 286 [MHþ]
C15H16NO4B (MW: 287.12 g/mol). UV–vis(nm): λ1¼251 (Ɛ
¼2.51103), λ2¼330 (Ɛ¼3.30103), in ethanol. Elemental ana-
lysis (%): Found (Calc.) C 63.92 (63.19), H 5.25 (5.66), N 4.87 (4.91)
(Scheme 4).
2.2.1.5. Synthesis of B5 (3-((4-acetyl phenyl imino)methyl) phenyl
boronic acid). 4-amino acetophenone (0.135 g, 1 mmol) in 15 mL of
absolute ethanol and 3-formyl phenyl boronic acid (0.149 g,
1 mmol) in 15 mL of ethanol were mixed in a one-necked ﬂask and
Scheme 3. Synthesis of B3.
Scheme 4. Synthesis of B4 and B6.
Scheme 5. Synthesis of B5, B7 and B8.
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was isolated after removal of the solvent and water, which was
washed with ethanol and water, and then dried in an oven. The
product is soluble in ethanol and DMSO. Mp: 110–120 °C. 1H NMR
(ppm, DMSO-d6):δ 8.63 (CH¼N), 4.38 (Ph–B(OH)2). FTIR-ATR
(cm1):3344 (BO–H), 698 ν(B–Ph), 1623 ν(CH¼N). m/z:268
[MþHþ] C15H14NO3B (MW:267.09 g/mol). UV–vis(nm):λ1¼202 (Ɛ
¼2.02103), λ2¼398 (Ɛ¼3.98103), in ethanol (Scheme 5).
2.2.1.6. Synthesis of B6 (3-((2,6-dimethoxy phenyl imino)methyl)-4-
ﬂuoro phenyl boronic acid). 4-ﬂouro-3-formyl phenyl boronic acid
(0.167 g, 1 mmol) in 20 mL of absolute ethanol and 2,6-dimethoxy
aniline (0.153 g, 1 mmol) in 15 mL of ethanol were mixed in a one-
necked ﬂask and heated under reﬂux at 100 °C for 24 h. The dark
brown solid product was obtained after removal of the solvent and
water, which was washed with ethanol and water, and then dried
in an oven. The product is soluble in ethanol and DMSO.
Mp:4250 °C. 1H NMR (ppm, DMSO-d6): δ¼8.70 (CH¼N), δ¼4.57
(Ph–B(OH)2). FTIR-ATR (cm1): 3374 (BO–H), 1583 ν(CH¼N), 1336
(Ph–F). m/z:304 [MþHþ] C15H15NO4BF (MW:303.09 g/mol). UV–
vis (nm): λ1¼212 (Ɛ¼2.12103), λ2¼340 (Ɛ¼3.40103), in
ethanol. Elemental analysis (%): Found (Calc.) C 61.67 (61.44), H
3.90 (4.09), N 5.16 (4.97) (Scheme 4).
2.2.1.7. Synthesis of B7 (3-((4-acetylphenyl imino) methyl)-4-ﬂuoro
phenyl boronic acid). 4-amino acetophenone (0.135 g, 1 mmol) in
15 mL of absolute ethanol and 4-ﬂouro-3-formyl phenyl boronic
acid (0.167 g, 1 mmol) in 15 mL of ethanol were mixed into a one-
necked ﬂask and heated under reﬂux at 100 °C for 24 h. The red-
dish solid product was collected after removal of the solvent and
water, which was washed with ethanol and water, and then dried
in an oven. The product is soluble in ethanol and DMSO. Mp: 116–120 °C. 1H NMR (ppm, DMSO-d6): δ 8.77 (CH¼N), 4.38
(Ph–B(OH)2). FTIR-ATR (cm1): 3348 (BO–H), 1623 ν(CH¼N), 1336
(Ph–F). m/z: 286 [MþHþ] C15H13NO3BF (MW: 285.08 g/mol). UV–
vis(nm): λ1¼203 (Ɛ¼2.03103), λ2¼323 (Ɛ¼3.23103), in
ethanol (Scheme 5).
2.2.1.8. Synthesis of B8 (3-((4-acetyl phenyl imino)methyl)-4-meth-
oxy phenyl boronic acid). 4-amino acetophenone (0.135 g, 1 mmol)
in 15 mL of absolute ethanol and 4-methoxy-3-formyl phenyl
boronic acid (0.179 g, 1 mmol) in 20 mL of ethanol were mixed into
a one-necked ﬂask and heated under reﬂux at 100 °C for 24 h. The
yellow solid product was obtained after removal of the solvent and
water, which was washed with ethanol and water, and then dried
in an oven. The product is soluble in ethanol and DMSO. Mp:
155 °C. 1H NMR (ppm, DMSO-d6): δ 8.84 (CH¼N), 4.38
(Ph–B(OH)2). 13C NMR (ppm, DMSO-d6): 163.48 (CH¼N), 123.31
(Ph–C–B(OH)2). FTIR-ATR (cm1): 3306 (BO–H), 1620 ν(CH¼N).m/
z: 298 [MþHþ] C16H16NO4B (MW: 297.11 g/mol). UV–vis (nm):
λ1¼204 (Ɛ¼2.04103), λ3¼325 (Ɛ¼3.25103), in ethanol. Ele-
mental analysis (%): Found (Calc.) C 61.29 (61.68), H 4.91 (4.43), N
4.24 (4.51) (Scheme 5).
2.2.2. Anticancer assay
The anticancer activity of boronic compounds containing imine
ligands was evaluated by using PC-3 (Human Prostate Cancer
Cells-ATCCs CRL-1435™) and L929 cells (Mouse Fibroblast Cells-
ATCCs CCL-1™) as healthy cell line. Four concentrations (0.5, 1, 2,
and 5 mM) of boronic compounds were prepared in Dulbecco's
modiﬁed Eagle's medium (DMEM, Invitrogen, USA) containing 10%
fetal bovine serum (Invitrogen, USA), and 1% of penicillin, strep-
tomycin, and amphotericin (Lonza, USA). PC-3 and L929 cells were
seeded onto 96-well plates at a concentration of 5000 cells/well,
and then incubated at 37 °C in a humidiﬁed air atmosphere with
5% CO2 for 24 h for cell attachment. The prepared compounds
were added into the cultured cells, and incubated for 24, 48 and
72 h, respectively. Cell viability was measured by the 3-(4,5-di-
methyl-thiazol-2-yl)-5-(3-carboxy-methoxy-phenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium (MTS)-assay (CellTiter96 AqueousOne
Solution; Promega, Southampton, UK) according to the manufac-
turer's instructions. Cells were incubated with the MTS solution
for 2 h at 37 °C and absorbance was measured at 490 nm using an
ELISA plate reader (Biotek, Winooski, VT).
2.2.3. Disc-diffusion assay
Antimicrobial properties of boronic compounds containing
imine ligands were investigated against E. coli ATCC 25922, Pseu-
domonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC
25923, Methicillin-resistant Staphylococcus aureus, C. albicans and
A. niger by using disc-diffusion assay as described in the literature
[21]. For this aim, 100 mL of freshly prepared microbial suspensions
containing 108 CFU/mL of bacteria, 106 CFU/mL of yeast and
104 spore/mL of fungi were spread on nutrient agar, sabouraud
dextrose agar and potato dextrose agar, respectively. Black discs
(6 mm) impregnated with boron derivatives (20 mL) of the speci-
ﬁed concentrations were placed on the inoculated plates. Distilled
water (20 mL) was used as negative control. Oﬂaxacin (5 mg/disc)
and nystatin (100 mg/disc) were used as positive controls for bac-
terial and fungal species tested, respectively. The inoculated plates
were incubated at 3671 °C for 24 h for bacterial strains and 48 h
for yeast, and 2771 °C for 72 h for fungal isolate. Antimicrobial
activity was determined by measuring zone of inhibition around
the discs.
2.2.4. Antioxidant implementation
The antioxidant activity of boronic based compounds were
investigated by four common methods, BCB, DPPH, ABTS
S. Pasa et al. / Journal of Pharmaceutical Analysis 6 (2016) 39–4842and CUPRAC [13,14,22–26].
BCB process is based on the linoleic acid test system derived
from the oxidation of linoleic acids by measuring the inhibitions of
conjugated diene hydroperoxides. 10 mg of each compound was
dissolved in 10 mL of absolute ethanol to prepare the stock solu-
tions. 2, 5, 10 and 20 mL of stock solutions were diluted into 40 mL
with the absolute ethanol. Then 160 mL of β-carotene solutions
were added into each well in the micro plate. As soon as they were
mixed, the absorbance was measured at 490 nm at the beginning.
Then they were kept at 50 °C for 120 min. The ranges of BCB were
calculated according to the Eq. (1):
= ( ) ( )R a b tln / / 1
where ln is the natural logarithm; a is the initial absorbance; b is
the incubation; t is the time (min).
The total antioxidant activities were also calculated as per-
centages according to the control compound using Eq. (2):
( )
( )
= – × ( )⎡⎣ ⎤⎦R R R
Total antioxidant activity %Inhibition
/ 100 2control sample control
where Rcontrol is the color bleaching range of control, and Rsample is
the color bleaching range of sample.
Each of the boronic samples was applied three times. Alpha-
tocopherol (α-Toc) and di-butyl-hydroxy toluene (BHT) were used
as standard compounds.
DPPH is commonly used as control material for the evaluation
of molecules which can act as radical scavengers in the antioxidant
activity experiments. 10 mg of each compound was dissolved in
10 mL of absolute ethanol to prepare the stock solutions. 2, 5, 10
and 20 mL of stock solutions were diluted into 40 mL with the ab-
solute ethanol. Then 160 mL of DPPH solutions were added into
each well in the micro plate. After incubation under dark condition
at room temperature, the absorbances were measured at 517 nm.
Free radical scavenging activities (% Inhibition) were calculated
according to Eq. (3):
= ( − ) × ( )A A A%Inhibition / 100 3control sample control
where A is the absorbance.
Each of the samples was applied three times to verify the re-
sults. α-Toc and BHT were also used as standard compounds.
ABTS is an assay depending on the radical cation decoloriza-
tion. In this assay, the addition of antioxidants into the solution
including radical cation form of the ABTS converted this com-
pound back into the neutral form in a variety of time-sclae. The
different antioxidant efﬁciencies of boronic compounds were re-
sponsible for this issue. The degree of decolorization as percentage
inhibition of ABTS  þ radical cation is obtained as a function of
time and concentration, and calculated relative to the activity of α-
Toc and BHT. The preparation of stock solutions was carried out by
dissolving 10 mg of each compound in 10 mL of absolute ethanol.
2, 5, 10 and 20 mL of stock solutions were diluted into 40 mL with
the absolute ethanol. Then 160 mL of ABTS solutions were added
into each well in the micro plate. After keeping them in tightened
place for 6 min in the absence of sunlight at room temperature,
the absorbances were measured at 734 nm. ABTS radical cation
decolorization activities as % Inhibition were determined by using
the Eq. (4):
= ( − ) × ( )A A A%Inhibition / 100 4control sample control
where A is the absorbance.
CUPRAC method comprises the reduction of Cu(II)-Neocuproine
into its colored form Cu(I)-Neocuproine chelate in the presence of
antioxidant compounds. The absorbance at 450 nm was measured
when the complex was obtained. Cu(II), Neocuproine and NH4OAcwere added into the prepared solutions to adjust the concentra-
tions as 10, 25, 50, and 100 mg/mL. The absorbance values were
compared with the standard molecules α-Toc and BHT. Each of
samples was applied three times to verify the results.3. Results and discussion
3.1. Structure identiﬁcation of B1-8 compounds
In the 1H NMR spectrum of B1, a singlet resonances at 5.44 ppm
and 3.95 ppm corresponds to hydroxyl proton on aromatic ring
and methoxy group on naphthalene boronic acid structure [27–
29]. The exact mass was found as m/z 291.0838 corresponds to the
B1 structure with [MHþ] at negative scan by liquid chromato-
graphy mass spectrometry with ion trap time of ﬂight (LC–MS–IT–
TOF) (Fig. 1).
Stretching vibrations at a range of 1383–1324 cm1 and
723 cm1 substantiated the boron binding (B–O) over oxygen
atoms and the B–Ph bond [28,30,31]. Electronic transitions such
as π-π* and n-π*, are based on the aromatic ring and the
oxygen atoms which can be understood from the absorption
peaks at 296 and 311 nm. SEM and TGA results revealed im-
portant data about the physical properties of B1. The surface
morphology seemed like cotton or tobacco pieces with hetero-
geneous dispersion. B1 was analyzed under low vacuum (100 Pa)
mode with 1500 times magniﬁcation [32–35]. Its thermogram
explains the stable nature of the compound up to 282 °C. The
weight loss was determined in two steps as 58% and 23.5% at
different temperatures (Fig. 2).
The 1H NMR spectrum of B2 represented a singlet resonance at
5.44 ppm belonging to Ph–OH and the aromatic protons appear
between 6.52 and 8.01 ppm [27–29,36]. The exact mass value was
proved by mass spectrum that shows the most abundance ap-
proximately 106 intensity at 359 with the positive scan [MþHþ].
Similarly, stretching vibrations were assigned at the expected re-
gions for boron binding (B–O) and the B–Ph vibration. π-π* and
n-π* transitions were obtained at 216 and 334 nm, respectively
[37–39]. The physical appearance of compound in SEM looked like
crumbled rocks with a single phase. Thermal stability and weight
loss experiment of B2 were also evaluated by TGA [33–35] and it
was found that it was quite stable up to 400 °C. Two step de-
compositions were depicted on the thermogram. (Fig. 2).
Structure of B3 was conﬁrmed by resonances at 8.39 ppm for
azomethine proton (–CH¼N–), 5.77 ppm for boronic protons,
4.36 ppm for secondary amine proton (N–H), 1.06 ppm for the
primary amine protons (NH2) with the 1H NMR spectrum
[32,33,41,45]. m/z:284 [MþHþ] showed the molecular weight of
B3 in LC–MS analysis. The stretching vibration appeared at
3300–3200 cm1 due to the acidic proton, primary amine at
3342–3218 cm1, –CH¼N stretching vibration at 1601 cm1 in
the FTIR spectrum. Electronic transitions of B3 were determined at
202 and 321 nm due to the π-π* and n-π* transition, respec-
tively [33,36,37,39]. Surface structure seemed like severed rock
fragments in the SEM image. The thermal behavior of boronic
based structure was also meaningful due to the boron nature
[33,35,41]. There was no weight loss up to 310 °C and 62.85% of
weight loss was calculated after it was heated to 800 °C under
nitrogen atmosphere (Fig. 2).
The 1H NMR spectrum of B4 displayed a singlet resonance at
8.61 ppm for imine proton (–CH¼N–) and 5.05 ppm for
Ph–B(OH)2 protons [23,31,35]. Molecular weight was found as m/
z:286 by negative scan mode [MHþ] with C15H16NO4B formula.
The peak intensity corresponding to B4 was approximately
7.5106 in LC–MS. The free boronic (BO–H) stretching vibration at
3371 cm1, B–Ph stretching at 704 cm1 and azomethine
Fig. 1. LC–MS–IT–TOF spectra of B1.
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ture [28,37,42]. Two broad bands can be seen in the UV region at
251 nm and 330 nm which may be attributed to the π-π* and
n-π* electronic transitions, respectively [38,39]. SEM and TGA
results showed data about the physical features of B4. The SEM
image of B4 described the different particle sizes and agglomer-
ated forms as a result of the amorphous nature of B4. TGA analysis
clariﬁed the thermal stability of boronic based ligands, which was
quite stable up to 346 °C due to the insigniﬁcant weight loss [33–
35,43]. After heated at 800 °C, the decomposition was calculated in
two steps with the ranges of 37%–18% (Fig. 2).
The 1H NMR spectrum of B5 illustrated the resonances at
8.63 ppm and 4.38 ppm corresponding to imine proton (–CH¼N–)
and boronic protons (Ph–B–(OH)2), respectively [28,40]. The mo-
lecular weight was determined as m/z:268 by positive scan mode
[MþHþ]. Stretching vibrations at 3344 cm1, 698 cm1 and
1623 cm1 may be assigned to BO–H, B–Ph, CH¼N bonds, re-
spectively and the peak at 759 cm1 was assigned to the B–Ph
vibration [28,30,31,36,44]. π-π* and n-π* transitions were ob-
tained at 202 nm and 398 nm, respectively. The physical sem-
blance of compound in SEM showed crumbled rocks with homo-
genous dispersion [32–35]. Thermal stability was found quite ﬁne
up to 300 °C and the thermogram of B5 illustrated the single step
decomposition (Fig. 2).
The analogue B6 was also characterized by 1H NMR spectrum
with meaningful resonances at 8.70 ppm and 4.57 ppm corre-
sponding to imine proton (–CH¼N) and boronic protons
(Ph–B(OH)2), respectively [27,28,40]. m/z:304 [MþHþ] proved the
mass value of B6 with C15H15NO4BF formula by applying positive
scan analysis in LC–MS. The stretching vibration of free boronic
group appeared at 3374 cm1. The peaks at 1583 cm1 and
758 cm1 also showed –CH¼N and B–Ph stretchings, respectively.
Electronic transitions of B6 were at 212 and 340 nm as π-π* and
n-π* transition, respectively [28,31,37,39]. Surface morphology
seemed like shredded leaf pieces in SEM image. It was investigated
under 109 Pa pressure with 6000 times magniﬁcation
[32,33,43,45]. The thermal behavior of boronic based compound
was found stable up to 230 °C. Then it started to decompose in two
steps with the ranges from 31% to 35% (Fig. 2)
The structures of B7 and B8 are different from each other due to
the existence of different substituents on the structure, namely,
ﬂuoride and methoxy groups. Resonances at 8.84 ppm and 8.77 ppm
corresponded to azomethine protons (–CH¼N–) and the peak at
4.38 ppm indicated the boronic acid protons [28,29,40,46]. Electronicbehaviors obtained by UV–vis presented two electronic transitions
arose from π-π* to n-π* at 203–323 nm and 204–325 nm, respec-
tively [37]. Mass spectra of B7 and B8 showed similar results with the
values of m/z:286 [MþHþ] C15H13NO3BF and m/z:298 [MþHþ]
C16H16NO4B, respectively. They demonstrated high intensities (1105
and 1.8107) by applying SIM (Selected Ion Monitoring) scan ex-
periment in LC–MS. The stretching vibrations for the BO–H, B–Ph and
CH¼N bonds were deﬁned at 3306–3348 cm1, 729–745 cm1 and
1620–1623 cm1, respectively [28,36]. The SEM image of B7 seemed
like crumbled rocks with heterogeneous distribution while B8 looked
like grinded crystal pieces with single phase and homogeneous
spread. Both particle sizes were determined approximately 10 mm
with the 6000 times enlargement. Thermal can be understood up to
220 °C and 143 °C by TGA thermograms [33–35,43]. Decompositions
of B7 and B8 are depicted in Fig. 2.
3.2. Anticancer activity
According to the results from the screening, the prostate cancer
cells (PC-3) were found to be the more sensitive cells towards the
treatment of B5 and B7 compounds, while these compounds
showed no toxicity on the healthy L929 cells (Fig. 3). The treat-
ment of compound B5 suggested a time- and dose-dependent
pattern and this compound displayed the highest toxicity on the
cell viability of PC-3 at 5 μM with the values of 33% on the 72 h
time period. However, it had no effect on the viability of L929 cells
and at the same time period and concentration of compound B5,
71% viable cells were observed (Fig. 3).
Interestingly, the identical time- and dose-dependent pattern
was observed in the case of compound B7 against both cancer cell
and healthy cell lines. The compound B7 showed similar cell via-
bility differentials with the values of 44% for the prostate cancer
cells (PC-3) at the concentrations of 5 mM and at 72 h. This com-
pound could reduce the viability of healthy L929 cells by the value
of 5% (95% viable cells) at 72 h (Fig. 4).
The results showed that boronic compounds containing imine
ligands speciﬁcally exhibited toxicity on prostate cancer cells.
Comparison of the cytotoxic activity of these two compounds
against cancer cells and toxicity levels against the healthy cells
revealed that the cancer cells were more sensitive to the boronic
compounds with the imine functionality compared to the normal
cells. Consequently, these two compounds could be entitled as
promising anticancer drug candidates for the drug design in can-
cer research.
Fig. 2. SEM images and TGA thermograms of compounds.
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The results revealed that boronic compounds displayed different
antimicrobial activities on bacteria, yeast and fungi tested (Table 1).B1 coded boron containing imine ligand displayed moderate effect
with a wide-range antimicrobial activity. It was found to be effective
against both methicillin-sensitive and methicillin-resistant S. aur-
eus, C. albicans and A. niger. The similar growth inhibitions were
Fig. 2. (continued)
S. Pasa et al. / Journal of Pharmaceutical Analysis 6 (2016) 39–48 45measured in the case of methicillin-sensitive S. aureus and methi-
cillin-resistant S. aureuswith the inhibition zone diameters of 7.5 mm
and 7.0 mm, respectively whereas the growth inhibition zone was
measured as 8.0 mm and 10.0 mm in case of the C. albicans and A.niger. On the other hand, B5 displayed antibacterial activity against S.
aureus and methicillin-resistant S. aureus with the values of 13 mm
and 9 mm, respectively. This compound could not inhibit the rest of
the microorganisms. B7 coded boronic compound with imine ligand
Fig. 3. Cell viability of PC-3 and L929 treated with B5 (PC-3: human prostate cancer
cells, L929: mouse ﬁbroblast cells as healthy cell line, nc: negative control, pc:
positive control).
Fig. 4. Cell viability of PC-3 and L929 treated with B7 (PC-3: human prostate cancer
cells, L929: mouse ﬁbroblast cells as healthy cell line, nc: negative control, pc:
positive control).
Table 1
Antimicrobial activities of boronic compounds on different microorganisms by
disc-diffusion assayn (SD70.5–1.0 mm).
Microorganisms Inhibition zone diameter (mm) Positive control
B1 B5 B7
Staphylococcus aureus
ATCC25923
7.570.5 1371 8.570.5 2671
Escherichia coli
ATCC25922
– – – 2873
Methicillin-resistant
Staphylococcus aureus
(MRSA)
770 971 – 1871
Pseudomonas
aeruginosa
ATCC27853
– – – 2272
Candida albicans 870 – – 1972
Aspergillus niger 1070 – – 2471
n Concentration of boronic compounds is 5 mg/mL, positive control: Oﬂaxacin
(5 mg/disc) and nystatin (100 mg /disc) for bacterial and fungal species, respectively.
S. Pasa et al. / Journal of Pharmaceutical Analysis 6 (2016) 39–4846had the weakest antimicrobial activity as it only inhibited S. aur-
eus growth with a zone diameter of 8.5 mm (Table 1).
3.4. Antioxidant activity
According to the results from the BCB method, B3, B4 and B6
were identiﬁed as the most effective compounds while B5 showed
a moderate activity and B7 was found to be the least active com-
pound for this assay. It can be seen from Fig. 5 that B3, B4 and B6
demonstrated better activity than the standard α-Toc whereas the
comparison between the standard BHT and these three com-
pounds showed that at 100 mg/mL concentrations there was less
than 15% difference for each compound. The antioxidant activity
pattern was found identical in the case of compounds B3 and B4 as
the higher concentrations showed the better activity. On the other
hand B6 was identiﬁed as the best compound due to the more
than 80% activity at 25 mg/mL (Fig. 5).
The second antioxidant assay by using the DPPH showed no
signiﬁcant efﬁciencies in case of the all boronic compounds with
imine ligands. It was considered that B2 and B3 were the least
active compounds with the 10% antioxidant activity at 100 mg/mL
concentrations. B4 and B6 showed similar antioxidant activity
pattern as the higher concentrations showed better activity.
However, the maximum amount of antioxidant activity was
achieved around 25% in the case of compound B4 at 100 mg/mL
and almost 40% in the case of compound B6 (Fig. 6).
ABTS radical cation quenching assay displayed distinguished
results for B2, B4 and B6. These compounds represented identical
antioxidant activity pattern with the both standards α-Toc and
BHT at the concentrations of 25, 50 and 100 mg/mL (Fig. 7). Fur-
thermore the antioxidant activities of these three compounds at
10 mg/mL concentrations were identiﬁed higher than both of the
standards. However, in the case of compounds B3 and B5, theantioxidant activities were determined as moderate, the com-
pounds B7 and B8 showed no activity for this assay.
CUPRAC process was also applied to identify the antioxidant
activity of boron complexes. B6 coded compound was reported as
the most efﬁcient compound among the tested compounds. The
comparison of this compound with the standard substances BHT
and α-Toc revealed that the compound B6 had an identical anti-
oxidant activity with α-Toc at the concentrations of 10, 25 and
50 mg/mL and higher efﬁciency at 100 mg/mL. It was also concluded
that compounds B4, B5 and B7 demonstrated half antioxidant
activity of with the BHT standard (Fig. 8).
Fig. 5. Antioxidant activity of boronic compounds with β-carotene bleaching (BCB).
Fig. 6. Antioxidant activity of boronic compounds with 2,2-diphenyl picryl hy-
drazyl (DPPH).
Fig. 7. Antioxidant activity of boronic compounds with 2,2′-azino-bis(3-ethylben-
zothiazoline-6-sulphonic acid) (ABTS).
Fig. 8. Antioxidant activity of boronic compounds with CUPric reducing anti-
oxidant capacity (CUPRAC).
S. Pasa et al. / Journal of Pharmaceutical Analysis 6 (2016) 39–48 474. Conclusions
In the present study, boronic compounds bearing imine were
synthesized, identiﬁed and then employed for prostate cancer treat-
ment. It was found that B5 and B7 demonstrated signiﬁcant cytotoxic
activity against the cancer cells whereas the healthy cells were pro-
tected by these compounds at higher percentages. The conclusion was
drawn as these compounds can be promising candidates for drug
design in cancer research. The antimicrobial features were studied by
various microorganisms and B1 was found to be the most efﬁcient
compound with the different amount of growth inhibition zone
against the four of these microorganisms. The antioxidant activities
were investigated by the BCB, DPPH, ABTS and CUPRAC methods and
the B6 displayed the highest antioxidant activity for all of these anti-
oxidant assays. The best data was collected from the ABTS assay and
compound B6 was reported better antioxidant agent than the two of
the standards BHT and α-Toc.Acknowledgments
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